宝ホ
ン
連結
Takara Holdings Inc. ‐Consolidated‐要約損益計算書
Consolidated Statements of Income by Business Group (Summary)
要約
借対照表
Consolidated Balance Sheets (Summary)
宝酒造
Takara Shuzo Group
要約損益計算書
Statements of Income (Summary)
要約
借対照表
Balance Sheets (Summary)
成
期
第 四半期決算短信補足資料
Supplement for the Consolidated Financial Statements
for the Second Quarter Ended September 30, 2008
タ
バ
Takara Bio Group
要約損益計算書
Statements of Income (Summary)
要約
借対照表
Balance Sheets (Summary)
事業 種類
セ メン 情報
Industry Segments Information
売
高及び営業損益
Sales and Operating Income.
成
期 業績
想
Financial forecast for the year ending March 31, 2009
宝ホ
ン
連結
Takara Holdings Inc. ‐Consolidated‐
宝酒造
Takara Shuzo Group
タ
バ
Takara Bio Group
FAX 075(241)5127
e-mail ir@takara.co.jp
IR
室
Investor Relations Office.将来見通
関す 注意事項
資料中 当社
び当社
現
計画 見通
戦略 確信
う
歴史的事実
いも
将来 業績 関す 見通
あ
現時
い 入手可能 情報
得
当社経営
断 基
くも
す
重大
や
確実性 含
い 情報
得
多く 仮定
び考え 基
も
あ
す 実際 業績
要素
測
大 く異
結果
得
知
く
い
実際 業績 影響
え 要素
経済情勢 特 消費動向
替
変動 法律 行政
度 変化
競合会社 価格 製品戦略
力 当社 既存製品
び新製品 販売力
生産中断 当社 知
的所
権 対す 侵害 急速
術革新 重大
訟
け
利
決等 あ
す
業績 影響
え
宝ホ ルディングス株式会社 I 室
Takara Holdings Inc. Investor Relations Office.
X
I
Forward-Looking Statements
Statements in this document, other than those based on historical fact, concerning the current plans, prospects, strategies and
expectations of the Company and its Group represent forecasts of future results. While such statements are based on the
conclusions of management according to information available at the time of writing, they reflect many assumptions and opinions
derived from information that includes major risks and uncertainties. Actual results may vary significantly from these forecasts due to
various factors.
宝ホ
ン
連結
:Takara Holdings Inc. ‐Consolidated‐要約損益計算書 :Consolidated Statements of Income by Business Group (Summary)
百万
:Millions of Yen成 期中間
FY2008(1st Half)
実績
想
実績
増減
比
増減
比
Actual Forecast announced May.2008 Actual change % difference %
宝酒造
タ
バ
そ 他
売
高
売
原価
売
総利益
運
費 保管料
広告宣伝費
研究開発費
管理費 そ 他
販売費及び一般管理費
宝酒造
タ
バ
そ 他
営業利益 △:損失
営業外収益
営業外費用
経常利益 △:損失
特
利益
特
損失
法人税
民税及び事業税
法人税等調整額
少数株主利益 △:損失
設備投資額
形 無形
減価償却費
形 無形
営業外収益
利息
郤当金
託研究補助金
Non-operating income Interest income 148, Dividend income 259, Grant received for R&D 8, etc.
営業外費用
支払利息
社債利息
替差損
持分法
投資損失
Non-operating expensesInterest expense 141, Bond interest 164, Foreign currency exchange losses 106, Equity in losses of associated companies 24, etc.
特
利益
形固定資産売却益
Extraordinary gain Gain on sales of property, plant and equipment 890, etc.
特
損失
和解費用引当金繰入額
卸資産評価損
固定資産売却
却損
投資
価証
評価損
Extraordinary loss Provision for loss on litigation settlement 125, Loss on valuation of inventories 95
Loss on disposals of property, plant and equipment 110, Loss on write-down of investment securities 105, etc
251
317
306
54
121.6%
ᇞ
10
96.6%
Interest and discounts expenses
そ 他営業外費用
324
82
261
ᇞ
62
80.6%
178
314.6%
Other,net
404
391
408
4
101.1%
17
104.4%
Interest income Dividends income
267
208
167
ᇞ
100
62.6%
ᇞ
40
80.4%
Other,net
利息 郤当金
そ 他営業外収益
Change from FY2008(1st Half) Difference from forecast anounced May.2008
FY2009(1Q-2Q)_4/1/08-9/30/08
成
期 第 四半期累計
対前期
対
想
Extraordinary loss
Current income taxes
Deferred income taxes Takara Shuzo Group
Cost of sales
Gross profit Other,net Takara Bio Group
Net sales
Sales promotion and allowance for s.p.
販売
進費 販売
進引当金繰入
Operating income(△:loss) Research and development Transportation and storage
Other,net Advertising
1,135
809
Net income(△:loss) SG&A expenses
Takara Shuzo Group
Takara Bio Group
Other,net
四半期純利益 △:損失
Extraordinary gain
税金等調整前四半期純利益 △:損失
Minority interests in net income△:loss Income(△:loss) before income taxes and minority interests Non-operating income
Non-operating expenses
Ordinary income(△:loss)
支払利息
ᇞ
819
41.5%
1,400
ᇞ
63
ᇞ
102
-
38
ᇞ
1,002
ᇞ
790
-
ᇞ
211
469
ᇞ
963
32.8%
1,582
447
139.4%
2,211
ᇞ
100
863
621
307.1%
133.7%
2,400
469
-
0
3,209
998
145.1%
1,432
575
300
2,758
ᇞ
22
99.2%
849
144.7%
1,900
567
ᇞ
8
98.5%
2,749
64
102.4%
167
ᇞ
23
96.0%
600
658
131.3%
2,100
921
57
106.7%
319
232
84
126.5%
371
1,249
2,132
14,338
1,900
10,929
32,069
ᇞ
469
671
2,684
2,780
1,592
1,603
10,654
134
269
576
ᇞ
95
85.8%
403
244.8%
1,100
ᇞ
748
97.7%
32,600
99.3%
2,692
1,443
215.5%
150.0%
117.7%
2,100
ᇞ
125
ᇞ
358
-
343
-
2,471
338
115.9%
141.8%
400
36
-
95.9%
99.8%
97.5%
84.4%
ᇞ
89
ᇞ
26
ᇞ
296
ᇞ
275
31,851
ᇞ
217
ᇞ
108
ᇞ
120
ᇞ
8
ᇞ
25
99.2%
99.5%
99.8%
2,172
14,432
1,611
10,679
2,153
2,064
14,312
44
101.4%
3,173
95.0%
91,195
34,500
57,377
34,600
ᇞ
153
99.6%
56,441
935
101.7%
100.9%
782
34,753
91,200
56,700
91,978
79,257
9,403
2,534
2,412
1,379
ᇞ
475
ᇞ
121
80,637
8,927
2,699
101.7%
94.9%
101.7%
79,300
9,201
1,337
ᇞ
274
97.0%
-
-
-
3,217
3,278
ᇞ
60
101.2%
100.9%
89.4%
677
ᇞ
285
778
98.2%
100.3%
100
95.2%
Capital expenditures
1,760
1,691
ᇞ
68
96.1%
ᇞ
118
95.5%
2,600
Depreciation and Amortization
2,659
2,481
ᇞ
177
93.3%
要約
借対照表
:Consolidated Balance Sheets (Summary)資産の部
:Assets百万
:Millions of Yen成
期
成
期第 四半期
増減
主 増減理由
FY2008 FY2009(2ndQ) Change Reference
流動資産
(Total current assets)
億 :One hundred millions of Yen
現金及び預金
TH △Cash and deposits
手形及び売掛金
T T △Notes and accounts receivable-trade
価証
T △ 宝酒造 譲渡性預金△Marketable securities TS △30.6 (Takara Shuzo Co., Ltd. :
Negotiable certificate of deposit △30 etc.
卸資産
T T △Inventories
そ 他
TH TOther current assets
倒引当金
Allowance for doubtful accounts
固定資産
形固定資産
形固定資産 増減Property, plant and equipment Reference of Property, plant and equipment
建物及び構築物
新規 得 T TBuildings and structures Newly purchases
114,650
120,796
ᇞ
6,146
23,554
26,529
ᇞ
2,975
46,441
46,990
ᇞ
549
14,625
18,132
ᇞ
3,506
25,202
25,096
106
4,989
4,209
780
ᇞ
162
ᇞ
160
ᇞ
1
82,169
87,047
ᇞ
4,877
45,119
47,341
ᇞ
2,221
16,275
16,387
ᇞ
112
機械装置及び運搬具
売却 却等 △ TH △Machinery, equipment and vehicles Sales, Retirement
土地
減価償却 △ T △ T △Land Depreciation
そ 他
そ 他増減 △ T T △Other property, plant and equipment O
無形固定資産
T △ T △Intangible fixed assets
投資そ 他 資産
Investments and other assets投資
価証
TH △ 時価評価Fa a △Investment securities △
そ 他
T TOther assets
倒引当金
Allowance for doubtful accounts
資産合計
Total assets
TH
=
Takara Holdings Inc. TS
=
Takara Shuzo Group TB
=
Takara Bio Group
12,298
13,059
ᇞ
761
13,376
14,547
ᇞ
1,171
3,169
3,345
ᇞ
175
5,225
6,561
ᇞ
1,336
31,824
33,144
ᇞ
1,320
24,436
26,122
ᇞ
1,686
196,820
207,843
ᇞ
11,023
7,804
7,427
377
ᇞ
416
ᇞ
405
ᇞ
11
要約
借対照表
:Consolidated Balance Sheets (Summary)負債及び純資産
の部
:Liabilities and net assets百万
:Millions of Yen成
期
成
期第 四半期
増減
主 増減理由
FY2008 FY2009(2ndQ) Change Reference
流動負債
(Total current liabilities)
億 :One hundred millions of Yen
支払手形及び
掛金
T T △Notes and accounts payable-trade
短期借入金
Short-term loans payable
1
償還 社債
TH △ aCurrent portion of bonds
未払酒税
TAccrued alcohol tax
未払費用
T △ 大 印 Ta P △Accrued expenses
販売
進引当金
宝酒造 Ta a aそ 他
T △ T △Other current liabilities
固定負債
(Total non-current liabilities)
社債
Bonds payable
長期借入金
TH △ 流動負債へLong-term loans payable
職給付引当金
T +Reserve for retirement benefits
預 金
T △Deposits from customers
そ 他
TH △ 繰延税金負債△Other non-current liabilities (Deferred tax liabilities △12.9
負債合計
Total liabilities
資本金
Capital stock
資本剰余金
Capital surplus
利益剰余金
Retained earnings
自己株式
TH △ 自己株式 得 千株Treasury stock Purchase of treasury stock
株主資本
(Total owner's equity)
そ 他
価証
評価差額金
TH △繰延
ッ 損益
替換算調整勘定
T △ T △USD=¥106.42 EUR=¥ GBP=¥212.31 (Jun-08)
USD=¥114.15 EUR=¥ GBP=¥228.05 (Dec-07)
評価 換算差額等
少数株主持分
(Minority interests)
純資産合計
Total net assets
負債純資産合計
Total liabilities and net assets
TH
=
Takara Holdings Inc. TS
=
Takara Shuzo Group TB
=
Takara Bio Group
196,820
207,843
ᇞ
11,023
12,871
13,303
ᇞ
432
110,535
113,273
ᇞ
2,737
Reserve for sales promotion expenses
13,226
13,226
-
86,284
94,570
ᇞ
8,285
6,537
6,639
ᇞ
102
8,899
116
4,394
5,705
ᇞ
1,310
ᇞ
121
3,201
3,204
ᇞ
2
77,975
77,342
633
ᇞ
503
ᇞ
2,145
ᇞ
20
92,257
92,761
ᇞ
46
ᇞ
1,011
ᇞ
1,134
(Total valuation and translation adjustments)
26
5,834
6,679
ᇞ
845
7,208
ᇞ
1,801
Valuation difference on available-for-sale securities
Deffered gains or losses on hedges
Translation adjustments
575
ᇞ
408
ᇞ
983
5,406
9,016
8,889
9,614
ᇞ
724
45,545
46,963
ᇞ
1,417
20,000
20,000
-
5,597
5,718
3,360
4,475
ᇞ
1,115
1,355
1,466
ᇞ
110
4,964
79
0
5,000
ᇞ
5,000
5,044
7,598
7,784
ᇞ
186
40,739
47,607
ᇞ
6,868
14,490
14,301
188
宝酒造
:Takara Shuzo Group要約損益計算書 :Statements of Income (Summary)
百万
:Millions of Yen成 期中間
FY2008(1st Half)
実績
想
実績
増減
比
増減
比
Actual Forecast announced May.2008 Actual change % difference %
焼郥
清酒
ソフ
コ
飲料
そ 他酒類
本
そ 他調味料
原料用
コ
等
そ 他
売
高
売
原価
売
総利益
運
費 保管料
広告宣伝費
研究開発費
商標使用料
管理費 そ 他
販売費及び一般管理費
営業利益 △:損失
営業外収益
営業外費用
経常利益 △:損失
特
利益
特
損失
法人税
民税及び事業税
法人税等調整額
少数株主利益 △:損失
設備投資額
形 無形
減価償却費
形 無形
101.2%
698
102.4%
63
101.7%
695
93.4%
98.8%
ᇞ
21
101.9%
102.8%
308
101.1%
101.1%
License for use of trademarks
5,794
Other
5,720
137
50,232
79,300
50,600
2,935
5,857
1,395
1,379
0
29,025
79,257
Transportation and storage
2,957
1,920
8
100.4%
2,325
Raw alcohol
2,004
2,334
329
116.4%
98.6%
7,619
100.7%
Hon Mirin
104.6%
2,660
2,764
18
Other seasonings
ᇞ
120
98.4%
7,636
ᇞ
103
3
101.7%
97.3%
1,800
-
-
ᇞ
48
-
98.4%
101.7%
ᇞ
134
ᇞ
171
ᇞ
116
11
1,337
100.1%
129.9%
1,100
ᇞ
62
99.8%
98.7%
342
131.5%
98.9%
Capital expenditures
927
1,015
87
109.4%
Depreciation and Amortization
1,889
1,751
ᇞ
138
92.7%
ᇞ
64
103.7%
102.9%
36,524
8,195
成
期 第 四半期累計
1,075
ᇞ
139
対前期
対
想
FY2009(1Q-2Q)_4/1/08-9/30/08 Change from FY2008(1st Half)
98.3%
Difference from forecast anounced May.200899.4%
102.9%
10,923
80,637
890
ᇞ
523
388
5,566
155
2,783
122
37,600
8,055
102.4%
93.9%
508
102.0%
8
2,030
13,788
169
100.5%
1,895
13,617
170
ᇞ
19
99.3%
98.7%
99.9%
89.9%
ᇞ
25
ᇞ
8
110.1%
28,700
51,628
29,008
ᇞ
16
99.9%
1,028
26,537
707
26,892
2,879
ᇞ
354
7,211
55
26,600
1,086
ᇞ
22
0
329
13,626
190
7,207
1,429
297
200
ᇞ
2
2,132
2,471
338
2,132
0
390
333
683.8%
57
296
2,106
90
ᇞ
133
7,328
274
92.5%
117.7%
2,100
2,548
415
119.5%
448
121.3%
115.9%
197
371
ᇞ
99
66.5%
2,100
74
99.7%
124
1,303
275
126.7%
1,028
124.3%
100
69
105.8%
1,200
ᇞ
34
99
-
24
124
Other,net Advertising
Sales promotion and allowance for s.p.
販売
進費 販売
進引当金繰入
Operating income(△:loss) Research and development
2,822
716
134.0%
130.1%
300
115
32
139.7%
82
115
-
422
117.6%
2,400
137.4%
200
Net income(△:loss) SG&A expenses
四半期純利益 △:損失
Extraordinary gain
Extraordinary loss
Current income taxes
Deferred income taxes
税金等調整前四半期純利益 △:損失
Minority interests in net income△:loss Income(△:loss) before income taxes and minority interests Non-operating income
Non-operating expenses
Ordinary income(△:loss) Shochu
Cost of sales
Gross profit
Light-alcohol refreshers Sake
Net sales
Other liquors
5,057
7,516
5,411
36,710
8,579
10,535
10,987
要約
借対照表
:Balance Sheets (Summary)資産の部
:Assets百万
:Millions of Yen成
期
成
期第 四半期
増減
主 増減理由
FY2008 FY2009(2ndQ) Change Reference
流動資産
(Total current assets)
億 :One hundred millions of Yen
現金及び預金
宝酒造 他Cash and deposits
手形及び売掛金
宝酒造 他Notes and accounts receivable-trade Takara Shuzo +10.7 etc.
価証
宝酒造 譲渡性預金△Marketable securities Takara Shuzo Co., Ltd. :
Negotiable certificate of deposit △30 etc.
卸資産
Inventories
そ 他
Other current assets
倒引当金
Allowance for doubtful accounts
固定資産
形固定資産
当中間期 形固定資産 増減Property, plant and equipment Reference of Property, plant and equipment and Intangible fixed assets
建物及び構築物
新規 得 +Buildings and structures Newly purchases
29,879
30,570
ᇞ
691
11,473
11,852
ᇞ
378
ᇞ
48
ᇞ
45
ᇞ
3
37,736
38,501
ᇞ
765
21,836
21,614
222
3,949
3,935
14
41,421
40,515
906
759
3,821
ᇞ
3,062
77,921
78,595
ᇞ
674
10,002
8,755
1,247
機械装置及び運搬具
減価償却 △Machinery, equipment and vehicles Depreciation
土地
そ 他増減 △Land O
そ 他
Other property, plant and equipment
無形固定資産
新規 得 減価償却 △ そ 他増減 △Intangible fixed assets Newly Purchases +0.1 Depresiation △2.1 Other, net △
投資そ 他 資産
Investments and other assets投資
価証
Investment securities
そ 他
繰延税金資産Other assets Deferred tax assets +1.1
倒引当金
Allowance for doubtful accounts
資産合計
Total assets
117,097
115,657
ᇞ
1,439
4,418
4,245
173
ᇞ
247
ᇞ
237
ᇞ
10
6,159
6,009
150
1,989
2,001
ᇞ
12
1,370
1,154
215
1,697
1,921
ᇞ
224
10,018
10,600
ᇞ
582
7,016
6,962
54
要約
借対照表
:Balance Sheets (Summary)負債及び純資産
の部
:Liabilities and net assets百万
:Millions of Yen成
期
成
期第 四半期
増減
主 増減理由
FY2008 FY2009(2ndQ) Change Reference
流動負債
(Total current liabilities)
億 :One hundred millions of Yen
支払手形及び
掛金
Notes and accounts payable-trade
短期借入金
宝酒造 宝HLD 運転資金借入Short-term loans payable Takara Shuzo Co.,Ltd. : Increase for operating funds
borrowing from Takara holdings inc.
未払酒税
酒類売 高減 減少Accrued alcohol tax Sales decrease of the alcoholic beverages business
未払費用
宝酒造 諸経費未払費用 △ 他Accrued expenses Takara Shuzo : Increase for Accrued Expenses △4.6 etc.
販売
進引当金
宝酒造Takara Shuzo +1.1
そ 他
未払法人税等 △ ほOther current liabilities Accrued income taxes △7.2 etc.
固定負債
(Total non-current liabilities)
長期借入金
Long-term loans payable
職給付引当金
Reserve for retirement benefits
預 金
引保証金返還2,797
ᇞ
186
3,293
ᇞ
496
1,355
1,466
ᇞ
110
32,989
32,593
396
11,898
11,813
84
2,879
740
2,139
7,598
7,784
97
6,460
7,495
ᇞ
1,034
14,649
14,639
10
109
116
ᇞ
7
7,703
7,605
Reserve for sales promotion expenses
預 金
引保証金返還Deposits from customers Repayments of guarantee deposits received
そ 他
Other non-current liabilities
負債合計
Total liabilities
資本金
Capital stock
資本剰余金
Capital surplus
利益剰余金
Retained earnings
株主資本
(Total owner's equity)
そ 他
価証
評価差額金
繰延
ッ 損益
替換算調整勘定
T a a aUSD=¥106.42 GBP=¥212.31 (Jun-08) USD=¥114.15 GBP=¥228.05 (Dec-07)
評価 換算差額等
少数株主持分
(Minority interests)
純資産合計
Total net assets
負債純資産合計
Total liabilities and net assets
2,779
2,738
40
115,657
117,097
ᇞ
1,439
68,017
69,864
ᇞ
1,846
65,692
67,062
ᇞ
1,370
ᇞ
20
ᇞ
46
26
ᇞ
16
15
32
6,609
ᇞ
102
330
307
22
6,506
-
8,013
9,384
ᇞ
1,370
47,639
47,232
406
1,000
1,000
-
56,678
56,678
ᇞ
453
63
ᇞ
449
78
ᇞ
527
ᇞ
517
Valuation difference on available-for-sale securities
Deffered gains or losses on hedges
Translation adjustments
(Total valuation and translation adjustments)
タ
バ
:Takara Bio Group要約損益計算書 :Statements of Income (Summary)
百万
:Millions of Yen成 期中間
FY2008(1st Half)
実績
想
実績
増減
比
増減
比
Actual Forecast announced May.2008 Actual change % difference %
研究用試薬
理化学機器
託 そ 他フ
ン
遺伝子工学研究 計
遺伝子医療
医食品バ
売
高
売
原価
売
総利益
運
費 保管料
広告宣伝費
研究開発費
商標使用料
Research reagents
Cost of sales
Gross profit
Contracted service and other Scientific instruments
Net sales
Transportation and storage
Advertising
Sales promotion
販売
進費
Research and development
Genetic engineering research segment
Gene medicine segment
Agribio segment
License for use of trademarks
107.7%
80
ᇞ
274
103.3%
ᇞ
19
96.0%
97.0%
25
576
0
67
ᇞ
71
0
85.1%
98.0%
109
78
ᇞ
30
72.2%
26.7%
97.5%
113.3%
8,328
ᇞ
294
96.4%
ᇞ
179
4,634
4,488
ᇞ
325
93.0%
5,901
1,343
1,083
94.8%
1,038
9,201
1,118
85.4%
8,927
ᇞ
270
ᇞ
196
35
7,897
ᇞ
431
951
ᇞ
14
965
94.9%
9,403
5
94
4,768
128
96
577
1,732
508
1,444
5
1,430
ᇞ
13
0
15
116.7%
26
99.0%
105.8%
108
98.5%
11
101.2%
ᇞ
475
4,713
4,309
4,618
ᇞ
149
96.9%
ᇞ
302
99.8%
82.6%
0
対前期
対
想
FY2009(1Q-2Q)_4/1/08-9/30/08 Change from FY2008(1st Half) Difference from forecast anounced May.2008
102.7%
5
940
8,192
93.7%
6,012
1,140
成
期 第 四半期累計
ᇞ
381
6
5,631
1,147
95.4%
9
113.5%
69
100.5%
ᇞ
94
管理費 そ 他
販売費及び一般管理費
遺伝子医療
医食品バ
共通
営業利益 △:損失
営業外収益
営業外費用
経常利益 △:損失
特
利益
特
損失
法人税
民税及び事業税
法人税等調整額
少数株主利益 △:損失
設備投資額
形 無形
減価償却費
形 無形
ᇞ
811
Agribio segment
ᇞ
352
ᇞ
360
ᇞ
8
-
110
70
5,182
4,535
ᇞ
437
ᇞ
405
Other,net
License for use of trademarks
ᇞ
313
ᇞ
171
-
-
ᇞ
613
ᇞ
61
-
ᇞ
299
73.9%
8
ᇞ
469
ᇞ
125
ᇞ
358
108.6%
126
-
-
ᇞ
922
ᇞ
811
0
-
Net income(△:loss) SG&A expenses
四半期純利益 △:損失
Extraordinary gain
Extraordinary loss
Current income taxes
Deferred income taxes
税金等調整前四半期純利益 △:損失
Minority interests in net income△:loss Income(△:loss) before income taxes and minority interests Non-operating income
Non-operating expenses
Ordinary income(△:loss) Operating income(△:loss)
Genetic engineering research segment
Gene medicine segment
Eliminations/Corporate
遺伝子工学研究
ᇞ
142
66
-
1
ᇞ
380
ᇞ
217
152
85
226.7%
67
76
35.6%
4
6
264.7%
4
ᇞ
141
-
ᇞ
2
1
0
351
263
-
0
219
ᇞ
993
18.1%
ᇞ
710
1.2%
-
ᇞ
367
1,212
13
206
1684.9%
ᇞ
103
ᇞ
454
-
232
74
90
-
ᇞ
388
136
ᇞ
55
71.0%
114
40
154.3%
8
474.2%
ᇞ
326
ᇞ
332
-
6
62
24
192
10
719
343
-
2,596
2,641
2,456
139
1,590
1,802
4,744
208
104.6%
ᇞ
543
ᇞ
137
-
105.7%
-
-
Capital expenditures
593
ᇞ
148
ᇞ
126
742
84.0%
791
-
79.9%
Depreciation and Amortization
706
664
ᇞ
41
94.1%
224
116.4%
1,366
ᇞ
211
88.2%
ᇞ
44
98.3%
91.5%
要約
借対照表
:Balance Sheets (Summary)資産の部
:Assets百万
:Millions of Yen成
期
成
期第 四半期
増減
主 増減理由
FY2008 FY2009(2ndQ) Change Reference
流動資産
(Total current assets)
億 :One hundred millions of Yen
現金及び預金
タ バ 宝生物工程 大連 △ ほCash and deposits △
手形及び売掛金
タ バ 売 高減 伴う減少 ほNotes and accounts receivable-trade Takara Bio Inc. : Decrease with the decrease of the sales etc.
価証
譲渡性預金等 資金運用Marketable securities Negotiable certificate of deposit etc.
卸資産
Inventories
そ 他
繰延税金資産 ほOther current assets Deferred tax assets +1.3 etc.
倒引当金
Allowance for doubtful accounts
固定資産
形固定資産
当中間期 形固定資産 増減Property, plant and equipment Reference of Property, plant and equipment and Intangible fixed assets
建物及び構築物
新規 得 +Buildings and structures Newly purchases
25,382
25,417
ᇞ
34
8,946
8,653
292
4,486
5,659
ᇞ
1,173
7,866
7,310
555
3,074
3,176
ᇞ
101
1,120
725
394
ᇞ
111
ᇞ
108
ᇞ
3
18,616
19,871
ᇞ
1,255
12,082
12,356
ᇞ
273
4,105
3,759
346
機械装置及び運搬具
減価償却 △Machinery, equipment and vehicles Accumulated depreciation
土地
そ 他増減 △Land O
そ 他
Other property, plant and equipment
無形固定資産
△ ほIntangible fixed assets Goodwill △ etc.
投資そ 他 資産
Investments and other assets投資
価証
株式売却ほInvestment securities Sales of Investments scurities etc.
そ 他
長期前払費用 投資そ 他 資産 △Other assets Long-term prepaid expenses +5.2
Investments and other assets △3.0
倒引当金
Allowance for doubtful accounts
資産合計
Total assets
2,094
2,262
ᇞ
167
4,625
4,633
ᇞ
7
1,257
1,701
ᇞ
444
3,330
4,432
ᇞ
1,102
3,203
3,083
119
302
404
ᇞ
101
43,998
45,289
ᇞ
1,290
2,900
2,679
221
0
0
0
要約
借対照表
:Balance Sheets (Summary)負債及び純資産
の部
:Liabilities and net assets百万
:Millions of Yen成
期
成
期第 四半期
増減
主 増減理由
FY2008 FY2009(2ndQ) Change Reference
流動負債
(Total current liabilities)
億 :One hundred millions of Yen
支払手形及び
掛金
Notes and accounts payable-trade
短期借入金
Short-term loans payable
そ 他
和解費用引当金 ほOther current liabilities Reserve for settlement payment of lawsuite +1.3 etc.
固定負債
(Total non-current liabilities)
長期借入金
Long-term loans payable
職給付引当金
Reserve for retirement benefits
そ 他
未払金 固定 △ ほOther non-current liabilities △
負債合計
Total liabilities
資本金
Capital stock
資本剰余金
ᇞ
13
18
ᇞ
174
487
6,167
6,180
9,040
9,022
941
1,115
501
ᇞ
13
955
922
32
2,561
2,374
186
2,384
2,539
ᇞ
155
44
44
-
3,783
3,641
142
1,177
1,221
ᇞ
44
資本剰余金
Capital surplus
利益剰余金
Retained earnings
自己株式
Treasury stock
株主資本
(Total owner's equity)
そ 他
価証
評価差額金
替換算調整勘定
T a a aUSD=¥106.42 =¥168.04 (Jun-08)
USD=¥114.15 =¥166.64 (Dec-07)
評価 換算差額等
少数株主持分
(Minority interests)
純資産合計
Total net assets
負債純資産合計
Total liabilities and net assets
0
-
26,967
18
ᇞ
634
Valuation difference on available-for-sale securities
Translation adjustments
0
26,949
1,401
2,035
(Total valuation and translation adjustments)
294
289
5
352
989
58
700
ᇞ
642
ᇞ
636
37,409
38,007
ᇞ
598
68
110
ᇞ
41
43,998
45,289
ᇞ
1,290
37,831
39,108
ᇞ
1,276
事業 種類
セ メン 情報
:Industry Segments Information売
高及び営業損益
:Sales and Operating Income売上高
:Total sales百万
:Millions of Yen増減
比
change %
酒類 食品
Alcoholic Beverages and Foods85,736
85,001
85,023
―
―
―
―
バ
Biomedical6,373
6,465
9,807
―
―
―
―
そ 他
Other5,050
4,794
4,760
―
―
―
―
消去又 全社
Eliminations/Corporateᇞ
3,435
ᇞ
3,611
ᇞ
3,258
―
―
―
―
酒類 調味料
Alcoholic Beverages and Seasonings―
―
83,284
74,797
76,012
1,215
101.6%
バ
Biomedical―
―
9,807
9,403
8,927
ᇞ
475
94.9%
物流
Transportation―
―
5,917
7,972
8,270
297
103.7%
そ 他
Other―
―
4,760
6,346
5,979
ᇞ
367
94.2%
消去又 全社
Eliminations/Corporate―
―
ᇞ
7,436
ᇞ
7,323
ᇞ
7,212
111
-
連結
Consolidated93,724
92,649
96,333
91,195
91,978
782
100.9%
営業費用
:Operating expenses酒類 食品
Alcoholic Beverages and Foods82,160
81,230
80,963
―
―
―
―
バ
Biomedical7,323
7,389
10,513
―
―
―
―
そ 他
Other4,832
4,526
4,473
―
―
―
―
消去又 全社
Eliminations/Corporateᇞ
3,062
ᇞ
3,193
ᇞ
2,856
―
―
―
―
郤賦 能営業費用Unallocated operating expenses ᇞ 472 ᇞ 465 ᇞ 515 ― ―
―
―
酒類 調味料
Alcoholic Beverages and Seasonings―
―
79,416
72,146
72,999
853
101.2%
バ
Biomedical―
―
10,513
9,165
9,047
ᇞ
117
98.7%
物流
Transportation―
―
5,729
7,800
8,110
310
104.0%
そ 他
Other―
―
4,473
6,334
5,936
ᇞ
398
93.7%
消去又 全社
Eliminations/Corporate―
―
ᇞ
7,038
ᇞ
6,935
ᇞ
6,865
69
-
郤賦 能営業費用Unallocated operating expenses ― ― ᇞ 515 ᇞ 504 ᇞ 449
55
-
連結
Consolidated91,254
89,952
93,094
88,510
89,228
717
100.8%
営業利益 △:損失
:Operating income(△:loss)酒類 食品
Alcoholic Beverages and Foods3,575
3,770
4,060
―
―
―
―
バ
Biomedicalᇞ
950
ᇞ
923
ᇞ
705
―
―
―
―
そ 他
Other217
268
286
―
―
―
―
消去又 全社
Eliminations/Corporateᇞ
372
ᇞ
418
ᇞ
402
―
―
―
―
酒類 調味料
Alcoholic Beverages and Seasonings―
―
3,868
2,651
3,013
362
113.7%
バ
Biomedical―
―
ᇞ
705
237
ᇞ
120
ᇞ
357
-
物流
Transportation―
―
187
172
159
ᇞ
12
92.6%
そ 他
Other―
―
286
12
43
30
348.7%
消去又 全社
Eliminations/Corporate―
―
ᇞ
398
ᇞ
388
ᇞ
346
42
-
連結
Consolidated2,470
2,697
3,238
2,684
2,749
64
102.4%
外部顧客に対する売上高
:Sales to customers百万
:Millions of Yen酒類 食品
Alcoholic Beverages and Foods85,644
84,833
84,805
―
―
―
―
バ
Biomedical6,363
6,460
9,620
―
―
―
―
そ 他
Other1,717
1,355
1,907
―
―
―
―
酒類 調味料
Alcoholic Beverages and Seasonings―
―
83,156
74,254
75,565
1,310
101.8%
バ
Biomedical―
―
9,620
9,072
8,655
ᇞ
416
95.4%
物流
Transportation―
―
1,648
4,235
4,398
162
103.8%
そ 他
Other―
―
1,907
3,632
3,358
ᇞ
273
92.5%
連結
Consolidated93,724
92,649
96,333
91,195
91,978
782
100.9%
FY2007(1st Half) FY2006(1st Half)
FY2005(1st Half)
a FY Ha
成
期
中間
成
期
中間
成
期
中間
前期対比
FY2008(1st Half) FY2009(1Q-2Q)
成
期
中間
成
期
第 四半期累計
成
期 業績
想
:Financial forecast for the year ending March 31, 2009宝ホ
ン
連結 :Takara Holdings Inc.
‐Consolidated‐百万
:Millions of Yen成
期
FY2008
実績
想
想
増減
比
増減
比
Actual Forecast announced May.2008Forecast announced Nov.2008 change % change %
宝酒造
タ
バ
そ 他
売
高
売
原価
売
総利益
運
費 保管料
広告宣伝費
研究開発費
管理費 そ 他
販売費及び一般管理費
宝酒造
タ
バ
そ 他
営業利益 △:損失
営業外収益
営業外費用
経常利益 △:損失
特
利益
特
損失
法人税
民税及び事業税
法人税等調整額
少数株主利益 △:損失
設備投資額
形 無形
減価償却費
形 無形
Depreciation and Amortization
5,455
5,200
ᇞ
255
95.3%
ᇞ
300
93.0%
4,300
Capital expenditures
3,852
4,000
147
103.8%
101.3%
168,800
20,300
2,200
ᇞ
749
96.3%
ᇞ
400
92.9%
5,600
4,850
4,211
ᇞ
728
38
171,000
421
106.4%
75,600
120,500
284
ᇞ
500
ᇞ
398
102.5%
104.3%
92.5%
191,878
19,550
102.5%
96.4%
6,578
91.8%
139
101.3%
74,014
5,400
194,500
118,900
7,000
6,860
195,400
ᇞ
325
100.5%
89.8%
1,600
ᇞ
550
900
102.0%
ᇞ
700
99.1%
4,358
29,373
3,643
21,553
4,325
4,000
30,100
3,800
21,300
101.0%
98.2%
88.4%
98.8%
66,200
692
ᇞ
358
726
156
ᇞ
253
ᇞ
800
98.8%
101.1%
322
104.5%
231
130.2%
1,000
400
ᇞ
154
72.2%
1,400
ᇞ
991
58.5%
300
ᇞ
710
29.7%
600
40
107.3%
0
100.0%
200
ᇞ
360
35.7%
100
200.0%
7,500
100
700
ᇞ
19
0
100.0%
1,000
ᇞ
730
57.8%
100
101.2%
8,700
193
102.3%
0
100.0%
97.3%
7,177
29,815
4,300
21,698
65,507
100
1,730
8,506
9,123
768
560
7,500
8,600
1,000
719
67,000
667
1,000
554
259
332
559
640
4,658
100.0%
111.1%
900
1,113
300
8,700
ᇞ
423
95.4%
1,000
ᇞ
113
89.8%
300.0%
56.6%
1,590
600
5,200
541
111.6%
8,321
270
ᇞ
405
3,798
32
0
100
ᇞ
1,100
500
110.6%
4,700
100
ᇞ
170
37.0%
140
154.3%
ᇞ
32
90.2%
ᇞ
40
93.6%
8,200
ᇞ
121
98.5%
2,900
ᇞ
493
85.5%
2,391
0
100.0%
8,700
900
ᇞ
690
1,200
700.0%
200
72.5%
4,000
Transportation and storage
Non-operating income
Non-operating expenses
Ordinary income(△:loss) Other,net
Advertising
Sales promotion and allowance for s.p.
販売
進費 販売
進引当金繰入
Operating income(△:loss)
利息 郤当金
Interest income Dividends income
そ 他営業外収益
そ 他営業外費用
Research and development
104.9%
1,010
ᇞ
600
93.2%
8,800
Net income(△:loss) SG&A expenses
Takara Shuzo Group
Takara Bio Group
Other,net
当期純利益 △:損失
Extraordinary gain
Extraordinary loss
Current income taxes
Deferred income taxes
税金等調整前当期純利益 △:損失
Minority interests in net income△:loss Income(△:loss) before income taxes and minority interests Other,net
Other,net
支払利息
Interest and discounts expenses
成
期
対前期
対
想
Takara Shuzo Group
Cost of sales
Gross profit Other,net Takara Bio Group
Net sales
Change from FY2008 Change from forecast anounced May.2008
FY2009_4/1/08-3/31/09
74,900
885
101.2%
117,864
2,635
102.2%
101.8%
3,521
100.8%
166,788
20,278
4,811
宝酒造
:Takara Shuzo Group
百万
:Millions of Yen成
期
FY2008
実績
想
想
増減
比
増減
比
Actual Forecast announced May.2008Forecast announced Nov.2008 change % change %
焼郥
清酒
ソフ
コ
飲料
そ 他酒類
本
そ 他調味料
原料用
コ
等
そ 他
売
高
売
原価
売
総利益
運
費 保管料
広告宣伝費
研究開発費
商標使用料
管理費 そ 他
販売費及び一般管理費
営業利益 △:損失
営業外収益
営業外費用
経常利益 △:損失
特
利益
特
損失
法人税
民税及び事業税
法人税等調整額
少数株主利益 △:損失
設備投資額
形 無形
減価償却費
形 無形
99.3%
98.5%
61,970
0
100.0%
166,788
101.5%
11,432
297
102.1%
ᇞ
137
2,200
102.7%
62,600
98.0%
100.9%
100.0%
ᇞ
1
139
290
105.5%
699
Shochu
Cost of sales
Gross profit
Light-alcohol refreshers Sake
Net sales
Other liquors
10,902
16,300
20,800
171,000
Hon Mirin Other seasonings5,309
Raw alcohol
5,600
Net income(△:loss) SG&A expenses
当期純利益 △:損失
Extraordinary gain
Extraordinary loss
Current income taxes
Deferred income taxes
税金等調整前当期純利益 △:損失
Minority interests in net income△:loss Income(△:loss) before income taxes and minority interests
ᇞ
45
81.5%
Transportation and storage
Non-operating income
Non-operating expenses
Ordinary income(△:loss) Other,net
Advertising
Sales promotion and allowance for s.p.
販売
進費 販売
進引当金繰入
Operating income(△:loss) Research and development
License for use of trademarks
245
3,500
385
112.4%
3,433
14,858
6,267
3,893
1,500
6,064
97.6%
7,600
ᇞ
319
7,600
633
109.1%
6,966
0
100.0%
200
0
100.0%
3,500
564
100.0%
300
200
ᇞ
31
86.3%
231
200
0
100.0%
300
194
283.1%
0
105
100.0%
3,607
0
28,392
400
14,652
3,900
650
500
0
7,177
14,500
54,792
1,493
0
7,500
7,500
407
105.7%
7,092
7,500
0
7,500
322
104.5%
100.0%
3,900
0
100.0%
55,100
100.6%
292
108.1%
100.0%
0
307
55,100
100.0%
100.0%
500
ᇞ
150
76.9%
100.0%
500
500
ᇞ
64
88.6%
0
200
6
3,995
28,052
350
114.0%
3,600
28,700
400
0
102.1%
1,469
90.1%
102.3%
ᇞ
395
647
307
865
11,200
ᇞ
232
5,900
104.3%
73,679
23,777
19,934
76,400
23,000
103.7%
96.7%
20,937
16,160
106.2%
5,554
5,901
228
101.4%
16,071
345
102.4%
74,615
23,351
成
期
1,784
ᇞ
351
対前期
対
想
FY2009_4/1/08-3/31/09 Change from FY2008 Change from forecast anounced May.2008
2,720
ᇞ
777
Depreciation and Amortization
3,890
3,600
ᇞ
290
92.5%
Capital expenditures
2,229
2,600
370
116.6%
3,800
2,600
ᇞ
358
30
3,581
4,211
105.5%
49
94.7%
100.0%
ᇞ
200
0
ᇞ
152
102.5%
100.4%
629
101.0%
2,200
103.4%
335
102.1%
92.5%
101.1%
99.0%
100.0%
ᇞ
293
114.3%
4,900
103.2%
177
101.3%
132
11,622
Other
11,438
361
104,818
168,800
106,200
6,400
11,800
108,400
62,600
タ
バ
:Takara Bio Group
百万
:Millions of Yen成
期
FY2008
実績
想
想
増減
比
増減
比
Actual Forecast announced May.2008Forecast announced Nov.2008 change % change %
研究用試薬
理化学機器
託 そ 他フ
ン
遺伝子工学研究 計
遺伝子医療
医食品バ
売
高
売
原価
売
総利益
運
費 保管料
広告宣伝費
研究開発費
商標使用料
管理費 そ 他
販売費及び一般管理費
遺伝子医療
医食品バ
共通
営業利益 △:損失
営業外収益
営業外費用
経常利益 △:損失
特
利益
特
損失
法人税
民税及び事業税
法人税等調整額
少数株主利益 △:損失
設備投資額
形 無形
減価償却費
形 無形
96.4%
対前期
対
想
FY2009_4/1/08-3/31/09 Change from FY2008 Change from forecast anounced May.2008
10
License for use of trademarks
229
130
31
124.5%
18,096
Genetic engineering research segment
162
ᇞ
67
Gene medicine segment
94.4%
97.3%
ᇞ
1,219
2,073
Agribio segment
遺伝子工学研究
4,168
4,054
1,968
277
3,415
5,190
11
197
106.8%
140.5%
270
Research and development Net sales
0
100.0%
4,054
96.7%
ᇞ
170
91.8%
ᇞ
728
10,890
9,207
10,342
7
58
1,189
ᇞ
1
73
ᇞ
94
ᇞ
22
102.6%
38.2%
80
97.3%
106.6%
103.6%
104.2%
ᇞ
215
87.1%
1,671
Depreciation and Amortization
1,429
1,455
26
101.8%
96.2%
0
100.0%
1,588
Capital expenditures
1,505
1,288
ᇞ
217
85.5%
70.7%
ᇞ
44
17,485
ᇞ
595
1,902
ᇞ
65
ᇞ
611
12,963
2,538
成
期
ᇞ
720
17
12,242
2,556
96.5%
ᇞ
449
ᇞ
101
103.5%
100.7%
10,223
ᇞ
547
95.0%
20,278
18,080
96.3%
97.8%
96.6%
119
101.2%
ᇞ
202
10,055
9,409
ᇞ
848
91.6%
19,550
92
ᇞ
749
98.4%
2,657
2,730
104.1%
10,790
0
10,142
479
105.0%
60
1,115
3,296
4,983
10
153
1,211
3,906
5,237
ᇞ
491
ᇞ
46
119
207
0
250
ᇞ
429
36.8%
679
98.2%
99.1%
87.4%
9,663
ᇞ
647
94.0%
0
100.0%
250
274
ᇞ
123
68.9%
124
42
151.4%
8
560
82
29
94
414.0%
398
279
ᇞ
5
97.9%
100
200.0%
100
350
ᇞ
526
40.0%
200
ᇞ
360
35.7%
0.7%
1,196
8
876
350
0
100.0%
1,400
36
204
666.8%
-
0
240
ᇞ
1,160
17.1%
ᇞ
1,187
ᇞ
195
ᇞ
553
17.7%
671
314
37.8%
ᇞ
263
ᇞ
134
ᇞ
117
-
118
33.1%
9
ᇞ
188
-
54
246
ᇞ
6
3
ᇞ
6
32.8%
9
Net income(△:loss) SG&A expenses
当期純利益 △:損失
Extraordinary gain
Extraordinary loss
Current income taxes
Deferred income taxes
税金等調整前当期純利益 △:損失
Minority interests in net income△:loss Income(△:loss) before income taxes and minority interests Non-operating income
Non-operating expenses
Ordinary income(△:loss) Operating income(△:loss)
Genetic engineering research segment
Gene medicine segment Research reagents
Cost of sales
Gross profit
Contracted service and other Scientific instruments
Agribio segment
ᇞ
782
ᇞ
642
139
-
Transportation and storage
Other,net Advertising
Sales promotion
販売
進費
12,692
96.7%
2,594
20,300
2,686
ᇞ
1,556
ᇞ
337
-
ᇞ
114
129
-
ᇞ
1,784
Eliminations/Corporate